跳至主要内容
临床试验/NCT07569289
NCT07569289尚未招募2 期

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study

Bedaya Hospital1 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2026年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
164
试验地点
1
主要终点
Metaphase-II oocytes rate

研究概览

简要总结

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol [ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively ] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • POSEIDON group 3 and 4
  • GnRH antagonist IVF cycle

排除标准

  • Hypogonadotrophic hypogonadism
  • Endometriosis
  • History of recurrent abortion

研究组 & 干预措施

Double trigger

Experimental

GnRH agonist is administered 38 - 39 hours prior to ovum pick-up and HCG is administered 35 - 36 hours prior to ovum pick-up, respectively.

干预措施: Double trigger (Drug)

HCG trigger

Active Comparator

HCG is administered 35 - 36 h prior to ovum pick-up

干预措施: HCG trigger (Drug)

结局指标

主要结局

Metaphase-II oocytes rate

时间窗: Ten to fifteen days after starting ovarian stimulation

Number of MII oocyte/ number of cumulus oocyte complex

次要结局

  • Clinical pregnancy rate(Five weeks after embryo transfer)
  • Ongoing pregnancy Rate(Eighteen weeks after embryo transfer)

研究者

发起方
Bedaya Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验